CLINICAL STUDIES
High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial
Aylee Liem, MD*,
Felix Zijlstra, MD*,
Jan Paul Ottervanger, MD*,
Jan C. A. Hoorntje, MD*,
Harry Suryapranata, MD, FACC*,
Menko-Jan de Boer, MD* and
Freek W. A. Verheugt, MD, FACC
* Hospital De Weezenlanden, Zwolle, the Netherlands
University Hospital Nijmegen, Nijmegen, the Netherlands
Manuscript received March 24, 1999;
revised manuscript received October 20, 1999,
accepted November 15, 1999.
Reprint requests and correspondence: Dr. Felix Zijlstra, Department of Cardiology, Hospital De Weezenlanden, Groot Wezenland 20, 8011 JW Zwolle, the Netherlands.
v.derks{at}diagram-zwolle.nl
OBJECTIVES
In the Heparin in Early Patency (HEAP) pilot study a beneficial effect of high-dose heparin on early patency in acute myocardial infarction (MI) was observed in a matched-control study.
BACKGROUND
High dose bolus intravenous injection of heparin may achieve lysis of coronary thrombi and could enhance early patency of the infarct related vessel in patients with MI scheduled for primary angioplasty.
METHODS
Before primary angioplasty, 584 patients with MI entered an open randomized trial of high dose (300 IU/kg) or low dose (0 or 5,000 IU) heparin. Of the 584 patients, 299 were randomized to high dose and 285 patients to low dose heparin.
RESULTS
Thrombolysis In Myocardial Infarction (TIMI) flow grade 2 or 3 was observed before primary angioplasty in 65 patients (22%) in the high dose group and 60 patients (21%) in the low dose heparin group (p > 0.1), whereas TIMI flow grade 3 was observed in 38 (13%) and 24 patients (9%), respectively (p = 0.11). There were no differences in the clinical end points between the two groups. There were no hemorraghic strokes, while 10% of the patients in the high dose group required blood transfusion versus 6% in the low dose/no heparin group (p = 0.07). No subsets of patients showed beneficial effects of high dose heparin, such as patients with longer delay between heparin administration and diagnostic angiogram or patients with short delay between symptom onset and admission.
CONCLUSIONS
There is no benefit of high dose bolus heparin on early patency compared with no or low dose heparin.
|
Abbreviations and Acronyms
| | HEAP | = Heparin in Early Patency | | LDH | = lactate dehydrogenase | | LVEF | = left ventricular ejection fraction | | MI | = myocardial infarction | | TIMI | = Thrombolysis In Myocardial Infarction |
|
This article has been cited by other articles:
|
|
|
|
 
P. J. Vlaar, T. Svilaas, K. Damman, B. J. G. L. de Smet, J. G. P. Tijssen, H. L. Hillege, and F. Zijlstra
Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review
Circulation,
October 28, 2008;
118(18):
1828 - 1836.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. G. Goodman, V. Menon, C. P. Cannon, G. Steg, E. M. Ohman, and R. A. Harrington
Acute ST-Segment Elevation Myocardial Infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest,
June 1, 2008;
133(6_suppl):
708S - 775S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Montalescot, H R Andersen, D Antoniucci, A Betriu, M J de Boer, L Grip, F J Neumann, and M T Rothman
Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction
Heart,
June 1, 2004;
90(6):
e37 - e37.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. De Luca, H. Suryapranata, F. Zijlstra, A. W. J. van't Hof, J. C. A. Hoorntje, A. T. M. Gosselink, J.-H. Dambrink, M.-J. de Boer, and ZWOLLE Myocardial Infarction Study Group
Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty
J. Am. Coll. Cardiol.,
September 17, 2003;
42(6):
991 - 997.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Zijlstra, N. Ernst, M.-J. de Boer, E. Nibbering, H. Suryapranata, J. C. A. Hoorntje, J.-H. E. Dambrink, A. W. J. van't Hof, and F. W. A. Verheugt
Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute st elevation myocardial infarction
J. Am. Coll. Cardiol.,
June 5, 2002;
39(11):
1733 - 1737.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Zijlstra
CORONARY DISEASE: Acute myocardial infarction: primary angioplasty
Heart,
June 1, 2001;
85(6):
705 - 709.
[Full Text]
|
|
|
|
|
|
|
J. P. Collet, G. Montalescot, C. Lesty, Z. Mishal, J. Soria, R. Choussat, G. Drobinski, C. Soria, P. Pinton, P. Barragan, et al.
Effects of Abciximab on the Architecture of Platelet-Rich Clots in Patients With Acute Myocardial Infarction Undergoing Primary Coronary Intervention
Circulation,
May 15, 2001;
103(19):
2328 - 2331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. K. French, T. A. Hyde, I. T. Straznicky, J. Andrews, M. Lund, D. J. Amos, A. Zambanini, C. J. Ellis, B. J. Webber, S. C. McLaughlin, et al.
Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction
J. Am. Coll. Cardiol.,
May 1, 2000;
35(6):
1516 - 1524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
